Latest News about AZN
Recent news which mentions AZN
Beat the Dow Jones With This Unstoppable Dividend Stock
February 08, 2023
From Motley Fool
AstraZeneca says Forxiga approved in EU for heart failure
February 07, 2023
Tickers
AZN
From MarketWatch
Danaher Shows Interest In Acquiring Catalent Valued At Significant Premium: Report
February 06, 2023
From Benzinga
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
From Motley Fool
Top 5 Health Care Stocks That May Rally
February 03, 2023
From Benzinga
Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst
February 02, 2023
From Benzinga
3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023
February 01, 2023
From Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
From Benzinga
Could This Vaccine Become Sanofi's Latest Blockbuster?
January 29, 2023
From Motley Fool
Could This Be Novartis' Next Blockbuster Medicine?
January 27, 2023
From Motley Fool
7 Dividend Stocks to Buy for a Stable Income Stream
January 27, 2023
From InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
January 26, 2023
From Motley Fool
The Top Healthcare Stocks to Buy With $100
January 23, 2023
From Motley Fool
One of the greatest cancer drugs ever has suddenly lost its edge. This is why it was vulnerable.
January 18, 2023
From MarketWatch
3 Growth Stocks Poised for Huge Gains in 2023
January 14, 2023
From Motley Fool
Why These Two Biotech Stocks Blasted Higher This Week
January 13, 2023
From Motley Fool
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
January 13, 2023
From MarketWatch
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
Could This New Drug Launch Be a Hit for Viatris?
January 12, 2023
From Motley Fool
From Benzinga
Why Is CinCor (CINC) Stock Up 138% Today?
January 09, 2023
From InvestorPlace
From Benzinga
From Benzinga
From InvestorPlace
From MarketWatch
Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
January 09, 2023
From MarketWatch
AstraZeneca will buy U.S.-based CinCor for cardiorenal asset
January 09, 2023
From MarketWatch
1 Stock Defying the Downturn to Buy, and 1 to Avoid
January 06, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.